PS999 SINGLE CELL SIGNALING PHARMACODYNAMICS IN A PHASE 1B CLINICAL TRIAL OF THE AXL INHIBITOR BEMCENTINIB IN ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME by Hellesøy, M., Fagerholt, O.H. E., Tislevoll, B.S., Gullaksen, S.E., Forthun, R.B., Hovland, R., Reikvam, H., Kittang, A.O., Cortes, J., Micklem, D., Holt, R.J., Loges, S., Gjertsen, B.T.

Request full text